Source: PR Newswire

Press Release: HSS : Elute Earns U.S. FDA Clearance for Its Novel Synthetic Resorbable Bone Void Filler

/PRNewswire/ -- For the thousands of patients in the United States requiring treatment for bone loss or defects caused by trauma or infections, Elute, Inc., a...

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Bryan T. Kelly's photo - President & CEO of HSS

President & CEO

Bryan T. Kelly

CEO Approval Rating

82/100

Read more